|
🐜
|
l-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
30 auth.
N. Schwab,
T. Schneider-Hohendorf,
V. Posevitz,
J. Breuer,
K. Göbel,
S. Windhagen,
B. Brochet,
P. Vermersch,
C. Lebrun-Frénay,
Anita Posevitz-Fejfár,
R. Capra,
L. Imberti,
V. Straeten,
J. Haas,
B. Wildemann,
...
J. Havla,
T. Kümpfel,
I. Meinl,
Kyle Niessen,
S. Goelz,
C. Kleinschnitz,
C. Warnke,
D. Buck,
R. Gold,
B. Kieseier,
S. Meuth,
J. Foley,
A. Chan,
D. Brassat,
H. Wiendl
|
7 |
2013 |
7
🐜
|
|
🐜
|
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab‐associated progressive multifocal leukoencephalopathy
24 auth.
C. Warnke,
G. Geldern,
P. Markwerth,
T. Dehmel,
R. Hoepner,
R. Gold,
M. Pawlita,
T. Kümpfel,
M. Mäurer,
M. Stangel,
...
F. Wegner,
R. Hohlfeld,
V. Straeten,
V. Limmroth,
T. Weber,
D. Hermsen,
C. Kleinschnitz,
H. Hartung,
M. Wattjes,
Anders Svenningson,
E. Major,
T. Olsson,
B. Kieseier,
O. Adams
|
6 |
2014 |
6
🐜
|
|
🐜
|
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
23 auth.
C. Warnke,
M. Stettner,
V. Lehmensiek,
T. Dehmel,
Anne K. Mausberg,
G. von Geldern,
R. Gold,
T. Kümpfel,
R. Hohlfeld,
M. Mäurer,
...
M. Stangel,
V. Straeten,
V. Limmroth,
T. Weber,
C. Kleinschnitz,
M. Wattjes,
A. Svenningsson,
T. Olsson,
H. Hartung,
D. Hermsen,
H. Tumani,
O. Adams,
B. Kieseier
|
6 |
2015 |
6
🐜
|
|
🐜
|
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation
23 auth.
S. Pfeuffer,
René Schmidt,
Frederike A. Straeten,
R. Pul,
C. Kleinschnitz,
Marinus Wieshuber,
De-hyung Lee,
R. Linker,
Sebastian Doerck,
V. Straeten,
...
S. Windhagen,
M. Pawlitzki,
C. Aufenberg,
M. Lang,
Christian Eienbroeker,
B. Tackenberg,
V. Limmroth,
B. Wildemann,
J. Haas,
L. Klotz,
H. Wiendl,
T. Ruck,
S. Meuth
|
4 |
2018 |
4
🐜
|
|
🐬
|
Different pharmacokinetics of cyclosporine A early and late after renal transplantation.
H. Wilms,
V. Straeten,
A. Lison
|
3 |
1988 |
3
🐬
|
|
🐬
|
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation
W. Liedtke,
K. Quabeck,
D. Beelen,
V. Straeten,
U. Schaefer
|
3 |
1994 |
3
🐬
|
|
🐜
|
The CSF JCV antibody index for diagnosis of natalizumab-associated PML
24 auth.
C. Warnke,
G. Geldern,
P. Markwerth,
T. Dehmel,
R. Hoepner,
R. Gold,
M. Pawlita,
T. Kuempfel,
M. Maeurer,
M. Stangel,
...
F. Wegner,
R. Hohlfeld,
V. Straeten,
V. Limmroth,
T. Weber,
D. Hermsen,
C. Kleinschnitz,
H. Hartung,
M. Wattjes,
Anders Svenningson,
E. Major,
T. Olsson,
B. Kieseier,
O. Adams
|
2 |
2014 |
2
🐜
|
|
🐢
|
[Pathogenesis and clinical course of acute ischemic cerebrovascular infarct in a community acute-care hospital. A retrospective study of 1,770 patients between 1984 and 1991].
J. Glahn,
V. Straeten
|
1 |
1994 |
1
🐢
|
